Skip to main content

Company for optimizing cancer therapy    +49-6221-8936-157     contact [at] therapyselect [dot] de   

Toggle menu
  • Home
  • Efficacy Tests for Cancer Drugs
    • General Information
      • Which Test for Whom?
      • Tumor Storage
      • Biomarker and Cancer
      • Chemosensitivity in Cancer
    • Using living tumor
      • CTR-Test® - Overview
      • CTR-Test® - Documents
      • Area of Application
      • Drug Selection
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about CTR-Test®
      • Quality Management
    • Using archived tumor
      • PCDx™ - Overview
      • PCDx™ - Documents
      • Area of Application
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about PCDx™
    • Using blood
      • Guardant360® - Overview
      • Area of Application
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about Guardant360®
  • Tumor Types
    • Bladder Cancer / Bladder Carcinoma
    • Brain Tumor / Glioma
    • Breast Cancer / Mamma Carcinoma
    • Cervical Cancer / Cervical Carcinoma
    • Colorectal Cancer / Colorectal Carcinoma
    • Lung Cancer – Non Small Cell Lung Carcinoma (NSCLC)
    • Lung Cancer – Small Cell Lung Carcinoma (SCLC)
    • Ovarian Cancer / Ovarian Carcinoma
    • Pancreatic Cancer / Pancreatic Carcinoma
    • Prostate Cancer / Prostate Carcinoma
    • Stomach Cancer / Gastric Cancer
  • Blog
  • News
  • About Us
    • Portrait
    • Management
    • Advisory Board
    • Cooperations
    • Awards
    • Job Openings
  • Contact

Search form

Blog - TherapySelect

Posted on Feb 25, 2020

Krebsdiagnostik

Next Generation Sequencing (NGS) – The fast reading of the genetic code

General Information Each cell contains a detailed blueprint of the genetic information in the form of a DNA double strand (quasi the book of life). The DNA in turn is composed of 4 different building blocks, the nucleotide bases (A, T, G and C) in variable order. This building plan (genetic code),...

Next-Generation Sequencing (NGS), Next-Generation Sequencing (NGS)

Posted on Feb 24, 2020

Krebstherapien

Does a doctor have to follow S3 guidelines when treating cancer patients?

General Information Medical guidelines are continuously being developed to support treating physicians in deciding for or against therapies in the treatment of their patients. S3 guidelines have the highest quality level and are prepared by a representative committee. They are based on a systematic...

Guidelines, Krebstherapie, Leitlinien

Posted on Feb 20, 2020

Krebsdiagnostik

Classification of cancer diseases

General Information When diagnosing cancer, patients are often confronted with confusing abbreviations (e.g. in a doctor's letter or pathology report), which are difficult for non-medical staff to understand. Therefore, we have briefly summarized the most important abbreviations for you. Different...

Classification, Klassifizierung

Posted on Aug 1, 2017

Krebsdiagnostik

What are Biomarkers?

General Definition Generally the term biomarkers comprises characteristic biological features, which can be molecular, anatomical, physiological or biochemical. These features can be measured and evaluated objectively, precisely and reproducibly. On the one hand they indicate the...

Posted on Oct 26, 2016

Krebstherapien

Holistic (biological) cancer therapy: Opportunities and limits

Cancer research has developed a variety of conventional medical treatments over the course of a century. Apart from this, biological or holistic cancer therapy exists. Rather than focusing on cancerous tumor, biological or holistic therapy considers the entire organism (body) of the patient. Its...

ganzheitliche Krebstherapie

Posted on Oct 19, 2016

Krebstherapien

Targeted Cancer Therapy: Main Points

Targeted cancer therapy, as well as chemotherapy , utilizes drugs to fight against cancer. However, drugs used for targeted therapy almost exclusively affect cancer tissue and mostly do not affect healthy cells. The targeted drugs function on cell level to limit tumor growth...

Zielgerichtete Krebstherapie, Personalisierte Onkologie, personalisierte Medizin, PCDx™, CTR-Test, Individualisierte Krebstherapie

Posted on Oct 12, 2016

Krebstherapien

Cytostatic Drugs as a Weapon against Cancer

The term cytostatic denotes an aggressive toxic substance, which is used for medical treatments. Cytostatic drugs slow down or stop the growth of specific cells by inhibiting their cell division. Depending on their specific mechanism of action, cytostatic drugs interfere with cell division in...

Zytostatikum, Zytostatika, PCDx™, CTR-Test

Posted on Oct 5, 2016

Krebstherapien

Anticancer Agents that can help Patients

Cancer is one of the most serious diagnoses for patients in our age, that affects thousands of men and women each year. There are as many variations of cancer as there are types of tissue in the body and they are also very different from one person to another. Each cancer is different in terms of...

alternative Krebsbehandlung
  • 1
  • 2
  • next ›
  • last »

logo_ts_2014.09.20_fk.png

TherapySelect Logo

Just call us:

Monday to Thursday from 9:00 - 16:00
and Friday from 9:00 - 15:00

Our phone number:
+49 6221-8936-157


Send us a message:

Link to contact form

We will get back to you as soon as possible.
Your TherapySelect Team



Some Awards

TherapySelect Dr. Frank Kischkel  |  Carl-Bosch-Str. 4  |  69115 Heidelberg  |  Germany
Tel: +49 – 6221 – 8936 – 157  |  Fax: +49 – 6221 – 8936 – 158  |  Email:
contact [at] therapyselect [dot] de  |  Sitemap

  • Home
  • Log in
  • Legal Notice
  • Data Privacy